Or Kalchiem-Dekel1, James G Connolly2, I-Hsin Lin3, Bryan C Husta1, Prasad S Adusumilli2, Jason A Beattie1, Darren J Buonocore4, Joseph Dycoco2, Paige Fuentes1, David R Jones2, Robert P Lee1, Bernard J Park2, Gaetano Rocco2, Mohit Chawla5, Matthew J Bott2. 1. Section of Interventional Pulmonology, Pulmonary Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. 2. Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY. 3. Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY. 4. Thoracic Pathology Service, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY. 5. Section of Interventional Pulmonology, Pulmonary Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address: chawlam1@mskcc.org.
Abstract
BACKGROUND: The landscape of guided bronchoscopy for the sampling of pulmonary parenchymal lesions is evolving rapidly. Shape-sensing robotic-assisted bronchoscopy (ssRAB) recently was introduced as means to allow successful sampling of traditionally challenging lesions. RESEARCH QUESTION: What are the feasibility, diagnostic yield, determinants of diagnostic sampling, and safety of ssRAB in patients with pulmonary lesions? STUDY DESIGN AND METHODS: Data from 131 consecutive ssRAB procedures performed at a US-based cancer center between October 2019 and July 2020 were captured prospectively and analyzed retrospectively. Definitions of diagnostic procedures were based on prior standards. Associations of procedure- and lesion-related factors with diagnostic yield were examined by univariate and multivariate generalized linear mixed models. RESULTS: A total of 159 pulmonary lesions were targeted during 131 ssRAB procedures. The median lesion size was 1.8 cm, 59.1% of lesions were in the upper lobe, and 66.7% of lesions were beyond a sixth-generation airway. The navigational success rate was 98.7%. The overall diagnostic yield was 81.7%. Lesion size of ≥ 1.8 cm and central location were associated significantly with a diagnostic procedure in the univariate analysis. In the multivariate model, lesions of ≥ 1.8 cm were more likely to be diagnostic compared with lesions < 1.8 cm, after adjusting for lung centrality (OR, 12.22; 95% CI, 1.66-90.10). The sensitivity and negative predictive value of ssRAB for primary thoracic malignancies were 79.8% and 72.4%, respectively. The overall complication rate was 3.0%, and the pneumothorax rate was 1.5%. INTERPRETATION: This study was the first to provide comprehensive evidence regarding the usefulness and diagnostic yield of ssRAB in the sampling of pulmonary parenchymal lesions. ssRAB may represent a significant advancement in the ability to access and sample successfully traditionally challenging pulmonary lesions via the bronchoscopic approach, while maintaining a superb safety profile. Lesion size seems to remain the major predictor of a diagnostic procedure.
BACKGROUND: The landscape of guided bronchoscopy for the sampling of pulmonary parenchymal lesions is evolving rapidly. Shape-sensing robotic-assisted bronchoscopy (ssRAB) recently was introduced as means to allow successful sampling of traditionally challenging lesions. RESEARCH QUESTION: What are the feasibility, diagnostic yield, determinants of diagnostic sampling, and safety of ssRAB in patients with pulmonary lesions? STUDY DESIGN AND METHODS: Data from 131 consecutive ssRAB procedures performed at a US-based cancer center between October 2019 and July 2020 were captured prospectively and analyzed retrospectively. Definitions of diagnostic procedures were based on prior standards. Associations of procedure- and lesion-related factors with diagnostic yield were examined by univariate and multivariate generalized linear mixed models. RESULTS: A total of 159 pulmonary lesions were targeted during 131 ssRAB procedures. The median lesion size was 1.8 cm, 59.1% of lesions were in the upper lobe, and 66.7% of lesions were beyond a sixth-generation airway. The navigational success rate was 98.7%. The overall diagnostic yield was 81.7%. Lesion size of ≥ 1.8 cm and central location were associated significantly with a diagnostic procedure in the univariate analysis. In the multivariate model, lesions of ≥ 1.8 cm were more likely to be diagnostic compared with lesions < 1.8 cm, after adjusting for lung centrality (OR, 12.22; 95% CI, 1.66-90.10). The sensitivity and negative predictive value of ssRAB for primary thoracic malignancies were 79.8% and 72.4%, respectively. The overall complication rate was 3.0%, and the pneumothorax rate was 1.5%. INTERPRETATION: This study was the first to provide comprehensive evidence regarding the usefulness and diagnostic yield of ssRAB in the sampling of pulmonary parenchymal lesions. ssRAB may represent a significant advancement in the ability to access and sample successfully traditionally challenging pulmonary lesions via the bronchoscopic approach, while maintaining a superb safety profile. Lesion size seems to remain the major predictor of a diagnostic procedure.
Authors: Thomas R Gildea; Peter J Mazzone; Demet Karnak; Moulay Meziane; Atul C Mehta Journal: Am J Respir Crit Care Med Date: 2006-07-27 Impact factor: 21.405
Authors: Alexander C Chen; Nicholas J Pastis; Michael S Machuzak; Thomas R Gildea; Michael J Simoff; Colin T Gillespie; Amit K Mahajan; Scott S Oh; Gerard A Silvestri Journal: Respiration Date: 2019-12-05 Impact factor: 3.580
Authors: Gerard A Silvestri; Benjamin T Bevill; Jing Huang; Mary Brooks; Yoonha Choi; Giulia Kennedy; Lori Lofaro; Alex Chen; M Patricia Rivera; Nichole T Tanner; Anil Vachani; Lonny Yarmus; Nicholas J Pastis Journal: Chest Date: 2020-01-21 Impact factor: 9.410
Authors: Lonny Yarmus; Jason Akulian; Momen Wahidi; Alex Chen; Jennifer P Steltz; Sam L Solomon; Diana Yu; Fabien Maldonado; Jose Cardenas-Garcia; Daniela Molena; Hans Lee; Anil Vachani Journal: Chest Date: 2019-11-01 Impact factor: 9.410
Authors: Mina Gaga; Charles A Powell; Dean E Schraufnagel; Nicolas Schönfeld; Klaus Rabe; Nicholas S Hill; Jean-Paul Sculier Journal: Am J Respir Crit Care Med Date: 2013-08-15 Impact factor: 21.405
Authors: Udit Chaddha; Stephen P Kovacs; Christopher Manley; D Kyle Hogarth; Gustavo Cumbo-Nacheli; Sivasubramanium V Bhavani; Rohit Kumar; Manisha Shende; John P Egan; Septimiu Murgu Journal: BMC Pulm Med Date: 2019-12-11 Impact factor: 3.317
Authors: Wendy Harris; Ellen Yorke; Henry Li; Christian Czmielewski; Mohit Chawla; Robert P Lee; Alexandra Hotca-Cho; Dominique McKnight; Andreas Rimner; D Michael Lovelock Journal: Med Phys Date: 2022-03-03 Impact factor: 4.071
Authors: Christina Bal; Casper Falster; Andre Carvalho; Nicole Hersch; Judith Brock; Christian B Laursen; Simon Walsh; Jouke Annema; Daniela Gompelmann Journal: ERJ Open Res Date: 2022-05-23
Authors: Janani Reisenauer; Jennifer D Duke; Ryan Kern; Sebastian Fernandez-Bussy; Eric Edell Journal: Mayo Clin Proc Innov Qual Outcomes Date: 2022-04-23